RT Journal
A1 Mitka M
T1 HEalth care fraud
JF JAMA
JO JAMA
YR 2012
FD February 8
VO 307
IS 6
SP 553
OP 553
DO 10.1001/jama.2012.90
UL http://dx.doi.org/10.1001/jama.2012.90
AB 
Enforcement actions involving the pharmaceutical industry were the source of the largest recoveries in 2011, totaling almost $2.2 billion. One of the largest recoveries reported by the Justice Department was $900 million from 8 drug makers to resolve allegations that they had engaged in unlawful pricing to increase profits. Another was $750 million paid by GlaxoSmithKline to resolve criminal and civil allegations that the company knowingly submitted, or caused to be submitted, false claims to government health programs for adulterated drugs and for drugs that failed to conform with the strength, purity, or quality specified by the Food and Drug Administration.